Oneview Healthcare Strengthens Cash with A$19 Million Placement and Pushes AI Care Assistant

Capital Raise Bolsters Balance Sheet Amid Challenging Markets

Oneview Healthcare PLC (ASX:ONE) closed the first quarter of 2026 with a cash balance of €10.3 million (A$17.1 million), more than doubling its reserves from the previous quarter. This jump was driven by a two-tranche placement that raised approximately A$19 million in gross proceeds, with the first tranche settled in late March contributing A$12 million. The second tranche, expected to add a further A$7 million, awaits shareholder approval at the company’s September annual general meeting. This approach avoids the cost and disruption of an extraordinary general meeting solely for the placement approval.

The capital raise comes after a period of restructuring completed in June 2025, which helped reduce operating costs and contributed to a lower net cash outflow of €1.1 million in Q1 2026, compared to €1.6 million in the same quarter last year. The company also completed a Security Purchase Plan (SPP) in April, raising a modest A$0.3 million, well below the initial A$2 million target, reflecting the cautious investor appetite seen in recent times. This follows the earlier placement and security purchase plan updates where the company had flagged the delay of tranche two approval and the underwhelming SPP uptake.

Expanding Footprint in US Healthcare Systems

Operationally, Oneview is making strides in expanding its customer base, particularly through its partnership with Baxter. In January 2026, Baxter amended its National Care Communication Agreement with a major US group purchasing organisation representing one of the country’s ten largest health systems. This network includes over 85 hospitals and 15,000 beds, now entering direct negotiations with Oneview on project scope and timing. This deal could significantly scale Oneview’s presence in the US market, a critical growth region for digital healthcare solutions.

The company’s traditionally strong first quarter for lead generation was supported by active participation in key industry conferences such as ViVE Health in Los Angeles, HIMSS in Las Vegas, and the AONL Conference in Chicago. These events underscored the growing demand for bedside digital technology as health providers seek to virtualise care delivery to address workforce shortages and improve operational efficiency.

Advancing AI-Enabled Care with Ovie

Oneview continues to develop Ovie, its AI-powered digitally integrated Care Assistant designed to orchestrate patient room workflows. Building on the voice assistant launched last year, Ovie aims to streamline non-clinical tasks by enabling patient self-service, efficient request routing, and enhanced operational visibility for care teams. The company expects to release a redesigned patient interface underpinning the Ovie ecosystem in the second half of 2026 and plans to pilot deployments with select customers within the year. This product development aligns with the broader industry trend toward digital transformation in healthcare, as providers seek smarter, more scalable solutions.

CEO James Fitter highlighted the company’s strengthened position, noting that the capital raise was a strong endorsement of Oneview’s strategy despite challenging market conditions. He emphasised the ongoing momentum driven by healthcare virtualisation and the company’s readiness to capitalise on new and expanded customer engagements throughout 2026.